[{"NetIncomeLoss_1_Q1_USD":14686984.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":245061587.0,"AssetsCurrent_0_Q1_USD":998560.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":2246491.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":176006.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q1_USD":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":11465331.0,"SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_0_Q1_USD":15168784.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"Liabilities_0_Q1_USD":27075275.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":947909.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":-14933024.0,"TemporaryEquityNetIncome_1_Q1_USD":48692.0,"CostsAndExpenses_1_Q1_USD":350905.0,"AssetsHeldInTrustNoncurrent_0_Q1_USD":276138312.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q1_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":615659.0,"PrepaidExpenseCurrent_0_Q1_USD":50651.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-15322.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":21320000.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":14638292.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":104823.0,"Assets_0_Q1_USD":277136872.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":0.0,"AdditionalPaidInCapital_0_Q1_USD":5606885.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"NonoperatingIncomeExpense_1_Q1_USD":15037889.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":280076.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":456082.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-607876.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":947909.0,"ProfitLoss_1_Q1_USD":14686984.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":1.28,"CashFDICInsuredAmount_0_Q1_USD":250000.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":277136872.0,"PreferredStockValue_0_Q1_USD":null,"InvestmentIncomeInterest_1_Q1_USD":42.0,"OperatingIncomeLoss_1_Q1_USD":-350905.0,"StockholdersEquity_0_Q1_USD":5000010.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"GeneralAndAdministrativeExpense_2_Q2_USD":404944.0,"GeneralAndAdministrativeExpense_1_Q2_USD":54039.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":10006116.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":10731693.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":2140282.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":176006.0,"AssetsCurrent_0_Q2_USD":838312.0,"SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_0_Q2_USD":19212004.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":240972620.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":0.0,"Liabilities_0_Q2_USD":31012286.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":791603.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-4088974.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":10586535.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":4043220.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":-10889804.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":0.0,"TemporaryEquityNetIncome_2_Q2_USD":11475.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":276146597.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":509450.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":0.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":21320000.0,"NonoperatingIncomeExpense_2_Q2_USD":11002954.0,"Assets_0_Q2_USD":276984909.0,"NetIncomeLoss_1_Q2_USD":-4088974.0,"NetIncomeLoss_2_Q2_USD":10598010.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":0.0,"AdditionalPaidInCapital_0_Q2_USD":9695811.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":791603.0,"NonoperatingIncomeExpense_1_Q2_USD":-4034935.0,"PrepaidExpenseCurrent_0_Q2_USD":46709.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":123770.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":299776.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-4696850.0,"StockholdersEquity_0_Q2_USD":5000003.0,"ProfitLoss_2_Q2_USD":10598010.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.41,"EarningsPerShareBasicAndDiluted_2_Q2_USD":0.99,"CashFDICInsuredAmount_0_Q2_USD":250000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":276984909.0,"PreferredStockValue_0_Q2_USD":0.0,"InvestmentIncomeInterest_1_Q2_USD":4838.0,"InvestmentIncomeInterest_2_Q2_USD":4880.0,"OperatingIncomeLoss_1_Q2_USD":-54039.0,"OperatingIncomeLoss_2_Q2_USD":-404944.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"UnrealizedGainLossOnInvestments_1_Q2_USD":3447.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":108270.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-19264.0,"Ticker":"GLS","CIK":"1805087","name":"CAPSTAR SPECIAL PURPOSE ACQUISITION CORP.","OfficialName":"Gelesis Holdings Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"341682749.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NYSE","SP500":"nan","filed":"20210816"}]